Skip to main content
. 2026 Feb 18;12(1):e006409. doi: 10.1136/rmdopen-2025-006409

Table 3. Comparative analysis of CoS and CoR familial Mediterranean fever patients.

Paediatric-diagnosis patients (n=170) Adult-diagnosis patients (n=66)
CoS
(n=85)
CoR
(n=85)
P value CoS
(n=33)
CoR
(n=33)
P value
Female, n (%) 51 (60) 51 (60) >0.999 16 (48.5) 16 (48.5) >0.999
Age at symptom onset, mean (SD) (years) 3.7 (3.3) 3.84 (3.5) 0.984 8.46 (6.2) 7.74 (6.4) 0.626
Age at first symptoms ≤3 years, n (%) 48 (56.5) 46 (54.1) 0.877 7 (21.2) 6 (18.2) >0.999
Age at diagnosis, mean (SD) (years) 6.76 (4.6) 6.78 (4.6) 0.976 32.98 (11.6) 33.08 (11.8) 0.995
Attack duration, mean (SD) (days) 2.59 (1.1) 2.65 (1.0) 0.689 3.39 (2.5) 3.29 (1.5) 0.187
Frequency of attacks ≥1 per month, n (%) 53 (62.4) 71 (83.5) 0.003 16 (48.5) 20 (60.6) 0.458
Clinical findings, n (%)
       
       Fever
       ELE
       Arthralgia
       Arthritis
       Abdominal pain
       Chest pain
59 (69.4)
28 (32.9)
55 (64.7)
13 (15.3)
76 (89.4)
47 (55.3)
74 (87.0)
41 (48.2)
67 (78.8)
35 (41.2)
81 (95.3)
40 (47.1)
0.009
0.061
0.061
<0.001
0.248
0.357
23 (69.7)
15 (45.5)
16 (48.5)
7 (21.2)
26 (78.8)
12 (36.4)
27 (81.8)
15 (45.5)
28 (84.9)
13 (39.4)
33 (97)
32 (97)
0.389
>0.999
0.004
0.181
0.054
>0.999
TURPAID score, mean (SD) 2.52 (0.6) 2.84 (0.7) 0.006 2.24 (0.6) 2.45 (0.6) 0.177
Patients with TURPAID score ≥2, n (%) 76 (89.4) 82 (96.5) 0.132 25 (75.8) 29 (87.9) 0.339

Variables in bold are statistically significant.

CoR, colchicine-resistance; CoS, colchicine-sensitive; ELE, erysipela-like erythema; TURPAID, Turkish Paediatric Autoinflammatory Diseases.